Literatur
Carr A, Samaras K, Chisholm DJ, Cooper DA (1998) Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351: 1881–1883
Foster DW (1998) The lipodystrophies and other rare disorders of adipose tissue. In: Fauci AS, Braunwald E, Isselbacher KJ et al. (eds) Harrison’s principles of internal medicine. McGraw-Hill, New York, pp 2209–2214
Mauss S, Wolf E, Jaeger H (1999) Reversal of protease inhibitor-related visceral abdominal fat accumulation with recombinant human growth hormone. Ann Intern Med 131: 313–314
Piliero PJ, Hubbard M, King J, Faragon JJ (2003) Use of ultrasonography-assisted liposuction for the treatment of human immunodeficiency virus-associated enlargement of the dorsocervical fat pad. Clin Infect Dis 37: 1374–1377
Safrin S, Grunfeld C (1999) Fat distribution and metabolic changes in patients with HIV infection. AIDS 13: 2493–2505
Saint-Marc T, Touraine JL (1999) Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitor therapy. AIDS 13: 1000–1002
Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H, Bousquet R, Katz P, Costagliola D, Katlama C (2003) Polylactid acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 17: 2471–2477
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hilton, S., Mauss, S., Ruzicka, T. et al. HALS: HIV-assoziiertes Lipodystrophiesyndrom. Hautarzt 56, 374–376 (2005). https://doi.org/10.1007/s00105-005-0925-6
Issue Date:
DOI: https://doi.org/10.1007/s00105-005-0925-6